Paul Singer Elliott Investment Management
Paul Singer is the founder of Elliott Investment Management, a major activist and multi-strategy firm. Elliott is known for event-driven investing, credit work, and high-profile campaigns at public companies. Singer’s firm combines deep legal and financial analysis with a willingness to engage managements and boards when it believes value can be unlocked.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CorMedix
CRMD
|
+$13.2M |
| 2 |
HDFC Bank
HDB
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$451M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$242M |
| 3 |
Cardinal Health
CAH
|
+$221M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$118M |
| 5 |
Southwest Airlines
LUV
|
+$46.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 12.93% |
| 2 | Industrials | 12.09% |
| 3 | Materials | 12.07% |
| 4 | Communication Services | 8.3% |
| 5 | Utilities | 2.6% |
Similar funds
Paul Singer's Q4 2024 Portfolio in Review
As of Q4 2024, Paul Singer held 62 positions worth $16.7B, down 14% from $19.3B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Paul Singer withdrew a net $2.58B in Q4 2024, closing 17 positions and reducing 6 holdings. Its most notable exit was CATALENT, INC., an estimated $242M position sold in full.
By sector, the portfolio is most concentrated in Energy at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Materials.
Against the trend, Paul Singer added an estimated $13.2M to CorMedix.
- Paul Singer added most to CorMedix in Q4 2024, an estimated $13.2M increase.
- Paul Singer's biggest Q4 2024 reduction was NRG Energy, cutting an estimated $451M.
- Paul Singer fully exited CATALENT, INC. in Q4 2024, selling an estimated $242M.
- Paul Singer's ten largest holdings make up 82% of its $16.7B portfolio in Q4 2024.
- Paul Singer opened 3 new positions and closed 17 in Q4 2024.
- Paul Singer's portfolio value fell 14% quarter-over-quarter to $16.7B.
Based on Elliott Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.